Split History
ETFs Holding HBIO »    HBIO Historical Stock Prices »



Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Harvard Bioscience develops, manufactures and sells technologies, products and services that enable fundamental develops in life science applications. Co.'s product families are cellular and molecular technology (CMT) and Preclinical. Co.'s CMT product family includes products supporting research related to molecular, cellular organ and organoid technologies, with additional application in the field of bio-production of pharmaceuticals and therapeutics. Co.'s Preclinical product family includes business lines that support the preclinical research and testing phase for drug development, and in particular testing related to data collection and analysis for safety and regulatory compliance. According to our HBIO split history records, Harvard Bioscience has had 1 split.
HBIO split history picture
Harvard Bioscience (HBIO) has 1 split in our HBIO split history database. The split for HBIO took place on November 04, 2013. This was a 1319 for 1000 split, meaning for each 1000 shares of HBIO owned pre-split, the shareholder now owned 1319 shares. For example, a 1000 share position pre-split, became a 1319 share position following the split.

When a company such as Harvard Bioscience splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business.

Looking at the HBIO split history from start to finish, an original position size of 1000 shares would have turned into 1319 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Harvard Bioscience shares, starting with a $10,000 purchase of HBIO, presented on a split-history-adjusted basis factoring in the complete HBIO split history. HBIO split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 05/28/2014
End date: 05/23/2024
Start price/share: $4.22
End price/share: $3.18
Dividends collected/share: $0.00
Total return: -24.64%
Average Annual Total Return: -2.79%
Starting investment: $10,000.00
Ending investment: $7,536.62
Years: 9.99
Date Ratio
11/04/20131319 for 1000
HBIO is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

HCA Split History
HEB Split History
HH Split History
HITK Split History
HMA Split History
HMSY Split History
HNSN Split History
HOLX Split History
HRC Split History
HSIC Split History

Also explore: HBIO shares outstanding history

Email EnvelopeFree HBIO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Tharimmune, Inc. (THAR)
BioCardia, Inc. (BCDA)
Lam Research Corporation (LRCX)
Akanda Corp. (AKAN)
Amphenol Corporation (APH)
Jaguar Health, Inc. (JAGX)
OpGen, Inc. (OPGN)
Blue Star Foods Corp. (BSFC)
Charles & Colvard, Ltd. (CTHR)
Seelos Therapeutics, Inc. (SEEL)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

HBIO Insider Buying

HBIO Split History | www.SplitHistory.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.